These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 19353238

  • 21. Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.
    El-Galaly TC, Cheah CY, Hutchings M, Mikhaeel NG, Savage KJ, Sehn LH, Barrington S, Hansen JW, Poulsen MØ, Smith D, Rady K, Mylam KJ, Larsen TS, Holmberg S, Juul MB, Cordua S, Clausen MR, Jensen KB, Bøgsted M, Johnsen HE, Seymour JF, Connors JM, Brown PD, Villa D.
    Br J Haematol; 2016 Dec; 175(5):876-883. PubMed ID: 27681999
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era.
    Fletcher CD, Kahl BS.
    Leuk Lymphoma; 2014 Oct; 55(10):2228-40. PubMed ID: 24286262
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.
    Feugier P, Virion JM, Tilly H, Haioun C, Marit G, Macro M, Bordessoule D, Recher C, Blanc M, Molina T, Lederlin P, Coiffier B.
    Ann Oncol; 2004 Jan; 15(1):129-33. PubMed ID: 14679132
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
    Ollila TA, Olszewski AJ.
    Curr Treat Options Oncol; 2018 Jun 21; 19(8):38. PubMed ID: 29931605
    [Abstract] [Full Text] [Related]

  • 29. [Central nervous system relapse in diffuse large B cell lymphoma: Risk factors].
    Sancho JM, Ribera JM, Working Group on Diagnosis, Prevention and Treatment of CNS Infiltration in Patients with DLBCL.
    Med Clin (Barc); 2016 Jan 15; 146(2):74-80. PubMed ID: 25817451
    [Abstract] [Full Text] [Related]

  • 30. Rituximab is associated with improved survival for aggressive B cell CNS lymphoma.
    Gregory G, Arumugaswamy A, Leung T, Chan KL, Abikhair M, Tam C, Bajel A, Cher L, Grigg A, Ritchie D, Opat S.
    Neuro Oncol; 2013 Aug 15; 15(8):1068-73. PubMed ID: 23502429
    [Abstract] [Full Text] [Related]

  • 31. Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.
    Shimada K, Murase T, Matsue K, Okamoto M, Ichikawa N, Tsukamoto N, Niitsu N, Miwa H, Asaoku H, Kosugi H, Kikuchi A, Matsumoto M, Saburi Y, Masaki Y, Yamamoto K, Yamaguchi M, Nakamura S, Naoe T, Kinoshita T, IVL Study Group in Japan.
    Cancer Sci; 2010 Jun 15; 101(6):1480-6. PubMed ID: 20412122
    [Abstract] [Full Text] [Related]

  • 32. Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era: findings from a large national database.
    Kumar A, Vanderplas A, LaCasce AS, Rodriguez MA, Crosby AL, Lepisto E, Czuczman MS, Nademanee A, Niland J, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, Abel GA.
    Cancer; 2012 Jun 01; 118(11):2944-51. PubMed ID: 22006274
    [Abstract] [Full Text] [Related]

  • 33. Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma.
    Mannisto S, Vähämurto P, Pollari M, Clausen MR, Jyrkkiö S, Kellokumpu-Lehtinen PL, Kovanen P, Karjalainen-Lindsberg ML, d'Amore F, Leppä S.
    Eur J Cancer; 2019 Jul 01; 115():27-36. PubMed ID: 31082690
    [Abstract] [Full Text] [Related]

  • 34. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.
    Kim SJ, Hong JS, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Kim YS, Yun HJ, Lee SI, Kim MK, Park EK, Kim WS, Suh C.
    Oncotarget; 2016 Nov 01; 7(44):72033-72043. PubMed ID: 27713132
    [Abstract] [Full Text] [Related]

  • 35. Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma.
    Kansara R.
    Curr Treat Options Oncol; 2018 Sep 10; 19(11):52. PubMed ID: 30203318
    [Abstract] [Full Text] [Related]

  • 36. The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.
    Tomita N, Yokoyama M, Yamamoto W, Watanabe R, Shimazu Y, Masaki Y, Tsunoda S, Hashimoto C, Murayama K, Yano T, Okamoto R, Kikuchi A, Tamura K, Sato K, Sunami K, Shibayama H, Takimoto R, Ohshima R, Takahashi H, Moriuchi Y, Kinoshita T, Yamamoto M, Numata A, Nakajima H, Miura I, Takeuchi K.
    Leuk Lymphoma; 2018 Jan 10; 59(1):97-104. PubMed ID: 28593796
    [Abstract] [Full Text] [Related]

  • 37. Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.
    Tanaka T, Shimada K, Yamamoto K, Hirooka Y, Niwa Y, Sugiura I, Kitamura K, Kosugi H, Kinoshita T, Goto H, Nakamura S.
    Ann Hematol; 2012 Mar 10; 91(3):383-90. PubMed ID: 21822617
    [Abstract] [Full Text] [Related]

  • 38. Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.
    Weng H, Shrestha PR, Hong H, Chen Z, Yu L, Yao Y, Zhang Z, Zou L, Zhu B, Zhou H, Liu X, Liu Y, Guo H, Huang H, Lin T.
    Cancer Med; 2023 Dec 10; 12(23):21188-21198. PubMed ID: 37997571
    [Abstract] [Full Text] [Related]

  • 39. [CNS involvement and the feasibility of intratecal chemotherapy administration in patients with a nodal form of diffuse large B-cell lymphoma not otherwise specified. Data of prospective study].
    Magomedova AU, Misyurina AE, Mangasarova JK, Gorenkova LG, Margolin OV, Fastova EA, Kravchenko SK.
    Ter Arkh; 2019 Jul 15; 91(7):35-40. PubMed ID: 32598734
    [Abstract] [Full Text] [Related]

  • 40. Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.
    Kim SJ, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C.
    Ann Hematol; 2011 May 15; 90(5):539-46. PubMed ID: 20960190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.